Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2015 (2015), Article ID 953868, 8 pages
http://dx.doi.org/10.1155/2015/953868
Research Article

A Novel Application of Multiscale Entropy in Electroencephalography to Predict the Efficacy of Acetylcholinesterase Inhibitor in Alzheimer’s Disease

1Neurology Department, National Yang-Ming University Hospital, Yi-Lan, Taiwan
2Neurology Department, National Yang-Ming University School of Medicine, Taipei, Taiwan
3Division of Pulmonology, Department of Internal Medicine, National Yang-Ming University Hospital, Yi-Lan, Taiwan
4Department of Internal Medicine, College of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
5Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan
6Center for Dynamical Biomarkers and Translational Medicine, National Central University, Chungli, Taiwan
7Research Center for Adaptive Data Analysis, National Central University, No. 300, Jhongda Road, Taoyuan 32001, Taiwan

Received 1 December 2014; Accepted 2 January 2015

Academic Editor: Kazeem O. Okosun

Copyright © 2015 Ping-Huang Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Sadock, V. A. Sadock, and H. I. Kaplan, Kaplan and Sadock's Comprehensive Textbook of Psychiatry, Lippincott Williams & Wilkins, 2005.
  2. L. P. Rowland and T. A. Pedley, Merritt's Neurology, Lippincott Williams & Wilkins, 2009.
  3. P. Davies and A. J. F. Maloney, “Selective loss of central cholinergic neurons in Alzheimer's disease,” The Lancet, vol. 2, no. 8000, p. 1403, 1976. View at Google Scholar · View at Scopus
  4. R. E. Davis, P. D. Doyle, R. T. Carroll, M. R. Emmerling, and J. Jaen, “Cholinergic therapies for Alzheimer's disease. Palliative or disease altering?” Arzneimittel-Forschung, vol. 45, no. 3, pp. 425–431, 1995. View at Google Scholar · View at Scopus
  5. E. Giacobini, “Pharmacotherapy of Alzheimer disease: new drugs and novel strategies,” Progress in Brain Research, vol. 98, pp. 447–454, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Greenberg, M. K. Tennis, L. B. Brown et al., “Donepezil therapy in clinical practice: a randomized crossover study,” Archives of Neurology, vol. 57, no. 1, pp. 94–99, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. S. L. Rogers, “Perspectives in the management of Alzheimer's disease: clinical profile of donepezil,” Dementia and Geriatric Cognitive Disorders, vol. 9, supplement 3, pp. 29–42, 1998. View at Google Scholar · View at Scopus
  8. S. L. Rogers, R. S. Doody, R. C. Mohs, and L. T. Friedhoff, “Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study,” Archives of Internal Medicine, vol. 158, no. 9, pp. 1021–1031, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. L. Rogers, M. R. Farlow, R. S. Doody, R. Mohs, and L. T. Friedhoff, “A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease,” Neurology, vol. 50, no. 1, pp. 136–145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Rogers and L. T. Friedhoff, “The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group,” Dementia, vol. 7, no. 6, pp. 293–303, 1996. View at Google Scholar · View at Scopus
  11. B. Winblad, L. Kilander, S. Eriksson et al., “Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study,” The Lancet, vol. 367, no. 9516, pp. 1057–1065, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Fillit and J. Hill, “Economics of dementia and pharmacoeconomics of dementia therapy,” The American Journal Geriatric Pharmacotherapy, vol. 3, no. 1, pp. 39–49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. B. Frisoni, “Reimbursement of acetilcholinesterase inhibitors for Alzheimer's disease in Europe,” International Journal of Geriatric Psychiatry, vol. 16, no. 2, pp. 233–235, 2001. View at Publisher · View at Google Scholar
  14. D. Getsios, S. Blume, K. J. Ishak, and G. D. H. Maclaine, “Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation,” PharmacoEconomics, vol. 28, no. 5, pp. 411–427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. R. Williams, A. Nazarians, and M. A. Gill, “A review of rivastigmine: a reversible cholinesterase inhibitor,” Clinical Therapeutics, vol. 25, no. 6, pp. 1634–1653, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Fun and S. J. Wang, “Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan,” International Journal of Geriatric Psychiatry, vol. 23, no. 1, pp. 73–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Giacobini, “Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 14, supplement 1, pp. S3–S10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Hanyu, Y. Tanaka, H. Sakurai, M. Takasaki, and K. Abe, “Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease,” Neuroscience Letters, vol. 319, no. 1, pp. 33–36, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kaduszkiewicz, T. Zimmermann, H.-P. Beck-Bornholdt, and H. D. van Bussche, “Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials,” British Medical Journal, vol. 331, no. 7512, pp. 321–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Mecocci, E. Grossi, M. Buscema et al., “Use of artificial networks in clinical trials: a pilot study to predict responsiveness to donepezil in Alzheimer's disease,” Journal of the American Geriatrics Society, vol. 50, no. 11, pp. 1857–1860, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Kanetaka, H. Hanyu, K. Hirao et al., “Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion,” Nuclear Medicine Communications, vol. 29, no. 6, pp. 568–573, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Hongo, S. Nakaaki, Y. Shinagawa et al., “SPECT-identified neuroanatomical predictor of the cognitive effects of donepezil treatment in patients with Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 26, no. 6, pp. 556–566, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Saumier, S. Murtha, H. Bergman, N. Phillips, V. Whitehead, and H. Chertkow, “Cognitive predictors of donepezil therapy response in alzheimer disease,” Dementia and Geriatric Cognitive Disorders, vol. 24, no. 1, pp. 28–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Chiaramonti, G. C. Muscas, M. Paganini et al., “Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type,” Neuropsychobiology, vol. 36, no. 3, pp. 153–158, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Etévenon, P. Péron-Magnan, B. Gueguen, M. Ghanem, J. Gaches, and P. Deniker, “Value of quantitative EEG and EEG mapping in medicine,” Annales de Medecine Interne, vol. 138, no. 1, pp. 13–18, 1987. View at Google Scholar · View at Scopus
  26. V. Knott, A. Labelle, B. Jones, and C. Mahoney, “Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment,” Schizophrenia Research, vol. 50, no. 1-2, pp. 41–53, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Rodriguez, P. Vitali, M. Canfora et al., “Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease,” Clinical Neurophysiology, vol. 115, no. 1, pp. 39–49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. G. Yener, A. F. Leuchter, D. Jenden, S. L. Read, J. L. Cummings, and B. L. Miller, “Quantitative EEG in frontotemporal dementia,” Clinical EEG Electroencephalography, vol. 27, no. 2, pp. 61–68, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Dauwels, F. Vialatte, and A. Cichocki, “Diagnosis of Alzheimer's disease from EEG signals: where are we standing?” Current Alzheimer Research, vol. 7, no. 6, pp. 487–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Dauwels, F. Vialatte, C. Latchoumane, J. Jeong, and A. Cichocki, “EEG synchrony analysis for early diagnosis of Alzheimer's disease: a study with several synchrony measures and EEG data sets,” in Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 2009, pp. 2224–2227, 2009.
  31. P. H. Tsai, C. Lin, J. Tsao et al., “Empirical mode decomposition based detrended sample entropy in electroencephalography for Alzheimer's disease,” Journal of Neuroscience Methods, vol. 210, no. 2, pp. 230–237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Jeong, “EEG dynamics in patients with Alzheimer's disease,” Clinical Neurophysiology, vol. 115, no. 7, pp. 1490–1505, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. K. J. Stam, D. L. J. Tavy, B. Jelles, H. A. M. Achtereekte, J. P. J. Slaets, and R. W. M. Keunen, “Non-linear dynamical analysis of multichannel EEG: clinical applications in dementia and Parkinson's disease,” Brain Topography, vol. 7, no. 2, pp. 141–150, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. C. J. Stam, B. Jelles, H. A. M. Achtereekte, S. A. R. B. Rombouts, J. P. J. Slaets, and R. W. M. Keunen, “Investigation of EEG non-linearity in dementia and Parkinson's disease,” Electroencephalography and Clinical Neurophysiology, vol. 95, no. 5, pp. 309–317, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Besthorn, R. Zerfass, C. Geiger-Kabisch et al., “Discrimination of Alzheimer's disease and normal aging by EEG data,” Electroencephalography and Clinical Neurophysiology, vol. 103, no. 2, pp. 241–248, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. C.-F. V. Latchoumane, F.-B. Vialatte, J. Solé-Casals et al., “Multiway array decomposition analysis of EEGs in Alzheimer's disease,” Journal of Neuroscience Methods, vol. 207, no. 1, pp. 41–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Escudero, D. Abasolo, R. Hornero, P. Espino, and M. Lopez, “Analysis of electroencephalograms in Alzheimer's disease patients with multiscale entropy,” Physiological Measurement, vol. 27, no. 11, pp. 1091–1106, 2006. View at Google Scholar
  38. T. Mizuno, T. Takahashi, R. Y. Cho et al., “Assessment of EEG dynamical complexity in Alzheimer's disease using multiscale entropy,” Clinical Neurophysiology, vol. 121, no. 9, pp. 1438–1446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-K. Peng, S. Havlin, H. E. Stanley, and A. L. Goldberger, “Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series,” Chaos, vol. 5, no. 1, pp. 82–87, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. Y.-L. Ho, C. Lin, Y.-H. Lin, and M.-T. Lo, “The prognostic value of non-linear analysis of heart rate variability in patients with congestive heart failure—a pilot study of multiscale entropy,” PLoS ONE, vol. 6, no. 4, Article ID e18699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. P. C. Ivanov, K. Hu, M. F. Hilton, S. A. Shea, and H. E. Stanley, “Endogenous circadian rhythm in human motor activity uncoupled from circadian influences on cardiac dynamics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 52, pp. 20702–20707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Hu, E. J. W. van Someren, S. A. Shea, and F. A. J. L. Scheer, “Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: involvement of the circadian pacemaker,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2490–2494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Hu, F. A. J. L. Scheer, P. C. Ivanov, R. M. Buijs, and S. A. Shea, “The suprachiasmatic nucleus functions beyond circadian rhythm generation,” Neuroscience, vol. 149, no. 3, pp. 508–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Costa, A. L. Goldberger, and C.-K. Peng, “Multiscale entropy analysis of complex physiologic time series,” Physical Review Letters, vol. 89, no. 6, Article ID 068102, 2002. View at Google Scholar · View at Scopus
  45. M. Costa, A. L. Goldberger, and C.-K. Peng, “Multiscale entropy analysis of biological signals,” Physical Review E. Statistical, Nonlinear, and Soft Matter Physics, vol. 71, no. 2, Article ID 021906, 2005. View at Publisher · View at Google Scholar · View at MathSciNet
  46. H.-K. Yuan, C. Lin, P.-H. Tsai et al., “Acute increase of complexity in the neurocardiovascular dynamics following carotid stenting,” Acta Neurologica Scandinavica, vol. 123, no. 3, pp. 187–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. P. J. Pan, P. H. Tsai, C. C. Tsai, C. L. Chou, M. T. Lo, and J. H. Chiu, “Clinical response and autonomic modulation as seen in heart rate variability in mechanical intermittent cervical traction: a pilot study,” Journal of Rehabilitation Medicine, vol. 44, no. 3, pp. 229–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Descarries, V. Gisiger, and M. Steriade, “Diffuse transmission by acetylcholine in the CNS,” Progress in Neurobiology, vol. 53, no. 5, pp. 603–625, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Matthews-Bellinger and M. M. Salpeter, “Distribution of acetylcholine receptors at frog neuromuscular junctions with a discussion of some physiological implications,” The Journal of Physiology, vol. 279, pp. 197–213, 1978. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Scimemi and M. Beato, “Determining the neurotransmitter concentration profile at active synapses,” Molecular Neurobiology, vol. 40, no. 3, pp. 289–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Google Scholar
  52. C. P. Hughes, L. Berg, and W. L. Danziger, “A new clinical scale for the staging of dementia,” British Journal of Psychiatry, vol. 140, no. 6, pp. 566–572, 1982. View at Publisher · View at Google Scholar · View at Scopus
  53. J. E. Cooper, “On the publication of the diagnostic and statistical manual of mental disorders: fourth edition (DSM-IV),” The British Journal of Psychiatry, vol. 166, no. 1, pp. 4–8, 1995. View at Publisher · View at Google Scholar
  54. M. R. Nuwer, “Assessing digital and quantitative EEG in clinical settings,” Journal of Clinical Neurophysiology, vol. 15, no. 6, pp. 458–463, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. N. E. Huang, Z. Shen, S. R. Long et al., “The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysis,” The Royal Society of London. Proceedings, Series A: Mathematical, Physical and Engineering Sciences, vol. 454, no. 1971, pp. 903–995, 1998. View at Publisher · View at Google Scholar · View at MathSciNet
  56. S. Pincus, “Approximate entropy (ApEn) as a complexity measure,” Chaos, vol. 5, no. 1, pp. 110–117, 1995. View at Publisher · View at Google Scholar · View at Scopus
  57. S. M. Pincus, “Approximate entropy as a measure of system complexity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 6, pp. 2297–2301, 1991. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  58. J. S. Richman and J. R. Moorman, “Physiological time-series analysis using approximate entropy and sample entropy,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 278, no. 6, pp. H2039–H2049, 2000. View at Google Scholar · View at Scopus
  59. B. Katz and R. Miledi, “The measurement of synaptic delay, and the time course of acetylcholine release at the neuromuscular junction,” Proceedings of the Royal Society of London Series B, vol. 161, pp. 483–495, 1965. View at Google Scholar · View at Scopus